Amir Ravandi
| Phone: | 1-204-237-2315 |
| Email: | aravandi@sbgh.mb.ca |
| Office: | University of Manitoba |
| Website: | Browse |
Research: Dr. Ravandi’s laboratory is to study lipid oxidation products and their contribution to cardiovascular pathology. The laboratory uses LC/MS/MS Lipidomic platform for quantitation and identification of lipid oxidation products in both animal models and clinical conditions to determine the involvement of oxidized lipids in both cardiac and vascular lesions. The ultimate goal is to not only identify the contribution of bioactive lipids to cardiac muscle injury but also to determine new therapeutic approaches to prevent the pathological effects of oxidized lipids. He is currently the Principal Investigator at the Cardiovascular Lipidomics Laboratory and Founder of the Interventional Cardiology Research Institute at St. Boniface Hospital in Winnipeg, Manitoba.